$8.08
-1.2-12.93%
At Close: -
$7.85
-0.23-2.85%
After Hours: 4:57 PM EDT
15 minutes delayed
Annovis Bio
ANVSNYSE
Annovis Bio (NYSE:ANVS) Stock, Analyst Ratings, Price Targets, Predictions
Annovis Bio Inc has a consensus price target of $38.17, established from looking at the 20 latest analyst ratings. The last 3 analyst ratings were released from Rodman & Renshaw, HC Wainwright & Co., and Rodman & Renshaw on July 2, 2024, June 12, 2024, and June 4, 2024. With an average price target of $52.33 between Rodman & Renshaw, HC Wainwright & Co., and Rodman & Renshaw, there's an implied 566.67% upside for Annovis Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Rodman & Renshaw
HC Wainwright & Co.
Rodman & Renshaw
Canaccord Genuity
Brookline Capital
1calculated from analyst ratings
Analyst Ratings for Annovis Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/02/2024 | Buy Now | 753.5% | Rodman & Renshaw | Elemer Piros | $67 → $67 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2024 | Buy Now | 192.99% | HC Wainwright & Co. | Raghuram Selvaraju | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | 753.5% | Rodman & Renshaw | — | → $67 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | 192.99% | HC Wainwright & Co. | Raghuram Selvaraju | $30 → $23 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 282.17% | HC Wainwright & Co. | Raghuram Selvaraju | — | Reiterates | Buy → Buy | Get Alert |
| 04/30/2024 | Buy Now | 231.21% | Canaccord Genuity | Sumant Kulkarni | $36 → $26 | Maintains | Buy | Get Alert |
| 04/02/2024 | Buy Now | 282.17% | HC Wainwright & Co. | Raghuram Selvaraju | $30 → $30 | Maintains | Buy | Get Alert |
| 03/21/2024 | Buy Now | 282.17% | HC Wainwright & Co. | Raghuram Selvaraju | → $30 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | 14.65% | Brookline Capital | Tyler Bussian | → $9 | Downgrade | Buy → Hold | Get Alert |
| 12/29/2023 | Buy Now | 358.6% | Canaccord Genuity | Sumant Kulkarni | → $36 | Initiates | → Buy | Get Alert |
| 11/28/2023 | Buy Now | 282.17% | HC Wainwright & Co. | Raghuram Selvaraju | → $30 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2023 | Buy Now | 282.17% | HC Wainwright & Co. | Raghuram Selvaraju | $40 → $30 | Maintains | Buy | Get Alert |
| 11/10/2023 | Buy Now | 345.86% | Brookline Capital | Tyler Bussian | → $35 | Initiates | → Buy | Get Alert |
| 08/15/2023 | Buy Now | 409.55% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2023 | Buy Now | 409.55% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | Buy → Buy | Get Alert |
| 06/09/2023 | Buy Now | 409.55% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | Buy → Buy | Get Alert |
| 04/21/2023 | Buy Now | 409.55% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | 409.55% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | → Buy | Get Alert |
| 09/08/2022 | Buy Now | 409.55% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Initiates | → Buy | Get Alert |
| 05/02/2022 | Buy Now | 371.34% | Ladenburg Thalmann | Aydin Huseynov | → $37 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Annovis Bio (ANVS) stock?
The latest price target for Annovis Bio (NYSE:ANVS) was reported by Rodman & Renshaw on July 2, 2024. The analyst firm set a price target for $67.00 expecting ANVS to rise to within 12 months (a possible 729.21% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Annovis Bio (ANVS)?
The latest analyst rating for Annovis Bio (NYSE:ANVS) was provided by Rodman & Renshaw, and Annovis Bio reiterated their buy rating.
When was the last upgrade for Annovis Bio (ANVS)?
There is no last upgrade for Annovis Bio
When was the last downgrade for Annovis Bio (ANVS)?
The last downgrade for Annovis Bio Inc happened on February 28, 2024 when Brookline Capital changed their price target from N/A to $9 for Annovis Bio Inc.
When is the next analyst rating going to be posted or updated for Annovis Bio (ANVS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Annovis Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Annovis Bio was filed on July 2, 2024 so you should expect the next rating to be made available sometime around July 2, 2025.
Is the Analyst Rating Annovis Bio (ANVS) correct?
While ratings are subjective and will change, the latest Annovis Bio (ANVS) rating was a reiterated with a price target of $67.00 to $67.00. The current price Annovis Bio (ANVS) is trading at is $8.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.